Minocycline for Symptom Reduction during Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial
The most debilitating symptoms during oxaliplatin-based chemotherapy in patients with colorectal cancer (CRC) are neuropathy and fatigue. Inflammation has been suggested to contribute to these symptoms, and the anti-inflammatory agent minocycline is safe and readily available.
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Xin Shelley Wang, Qiuling Shi, Nishin Bhadkamkar, Charles S. Cleeland, Araceli Garcia-Gonzalez, Jonathan Aguilar, Cobi Heijnen, Cathy Eng Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Eloxatin | Minocycline | Neurology | Pain | Pain Management | Palliative Care | Solodyn